Exblifep
NDC Package 83289-101-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Exblifep is a . Marketed by Allecra Therapeutics Sas, this product is identified by NDC 83289-101 and is authorized under FDA application NDA216165.

Identification & Billing

NDC Package Code
83289-101-02
Package Description
10 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
Product Code
83289-101
11-Digit Billing Format
83289010102

Clinical Specifications

Proprietary Name
Exblifep
Dosage Form
-

Regulatory & Marketing

Labeler Name
Allecra Therapeutics Sas
FDA Application #
NDA216165
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-28-2024
End Marketing Date
02-28-2024
Listing Expiration
02-28-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83289-101-02 identifies a specific commercial package of 10 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose of Exblifep, labeled by Allecra Therapeutics Sas. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Allecra Therapeutics Sas on February 28, 2024. The current certification is valid through February 28, 2024.

How is this Allecra Therapeutics Sas product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83289010102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83289-101-02
11-Digit CMS (5-4-2)
83289-0101-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.